Table 11.6i

Immunosuppression Use for Antirejection Treatment from Transplant

		Year of Transplant
		1998	1999	2000	2001	2002	2003	2004	2005	2006	2007
Transplants		2,348	2,188	2,199	2,202	2,155	2,057	2,015	2,125	2,193	2,209
Tx with Antirejection Treatments		980	916	901	849	803	656	533	533	488	430
Antibodies	Any in Category	21.3%	17.7%	16.3%	15.5%	17.4%	18.4%	15.6%	18.0%	19.3%	17.0%
	Atgam/NRATG/NRATS	7.2%	6.3%	4.6%	3.9%	4.0%	4.6%	2.6%	2.4%	3.7%	5.1%
	OKT3	15.0%	7.4%	5.1%	5.8%	6.8%	4.1%	3.2%	3.4%	3.7%	1.4%
	Thymoglobulin	0.2%	2.0%	3.8%	4.9%	6.4%	7.5%	8.6%	9.4%	11.3%	9.3%
	Zenapax	0.8%	2.5%	3.0%	2.5%	1.5%	2.0%	1.5%	3.6%	1.6%	2.6%
	Simulect	0.1%	0.9%	2.0%	0.4%	0.4%	1.4%	0.6%	0.8%	0.4%	0.2%
	Campath	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.2%	0.2%	0.2%	0.0%
Corticosteroids	Any in Category	87.8%	91.3%	92.3%	92.7%	92.2%	92.5%	91.4%	90.8%	90.4%	89.5%
Corticosteroids	Steroids	87.8%	91.3%	92.3%	92.7%	92.2%	92.5%	91.4%	90.8%	90.4%	89.5%
Antimetabolites	Any in Category	6.5%	4.6%	4.4%	2.0%	3.0%	3.5%	1.7%	2.3%	1.8%	2.3%
	Cytoxan	2.4%	2.1%	1.7%	0.5%	0.9%	1.7%	1.3%	1.3%	1.6%	2.1%
	Methotrexate	4.3%	2.6%	2.8%	1.5%	2.1%	1.8%	0.4%	0.9%	0.2%	0.2%